Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Sweet findings

This article was originally published in The Tan Sheet

Executive Summary

As little as 2 tablespoons of dark chocolate a day can almost halve the risk of a fatal heart attack in some men and women by "decreasing the tendency of platelets to clot in narrow blood vessels," according to a Nov. 14 presentation at the American Heart Association's Scientific Sessions in Chicago. Diane Becker, ScD, Johns Hopkins University School of Medicine, Bloomberg School of Public Health, Baltimore, Md. et al., conclude the "chemical in cocoa beans has a biochemical effect similar to aspirin in reducing platelet clumping." From 139 participants, aged 21 to 80, who were disqualified from a much larger study, "The Genetic Study of Aspirin Responsiveness," the researchers found it took 130 seconds for the chocolate group's platelets to clump together in a hair-thin plastic tube, while it took 123 seconds for the non-chocolate consumers...

You may also be interested in...

Hershey Looks For Sweet Spot In Promoting Pleasure, Benefits In Chocolate

Hershey performs a balancing act promoting the nutritional benefits of chocolate to target consumers who want snacks to "taste good and be good for us," but without making any disease claims, according to Debra Miller, the firm's clinical nutrition director

Pink Sheet Podcast: Woodcock To Be Acting US FDA Chief, Key Staff Depart, Political Donations Shift

Pink Sheet reporters and editor discuss President-Elect Joe Biden’s decision to name the CDER director as acting FDA commissioner and other staffing changes, as well as changes to industry trade groups’ political donations.

Liquid Biopsy Company Delfi Diagnostics Raised $100M For New Class of Early Cancer Detection Test

Delfi Diagnostics will use the new funds to expand its team of cancer researchers and machine-learning experts to validate its novel approach for early cancer detection through multiple prospective clinical trials. 





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts